Market Movers (8-K)
See all →NYSE
Westlake Chemical Partners LP announced second quarter 2026 results, reporting $14.2 million in net income and a significant increase in operating cash flow, while declaring its 48th consecutive quarterly distribution.
NYSE
Westlake Chemical Partners LP reported strong first quarter 2026 results, with net income and operating cash flow significantly increasing year-over-year, driven by higher production and sales volumes.
Better than expected
NYSE
Westlake Chemical Partners LP has appointed Jonathan H. Baksht as its new Senior Vice President and Chief Financial Officer, effective June 15, 2026.
NYSE
Westlake Chemical Partners LP announced its fourth quarter and full year 2025 results, highlighting a strong Q4 coverage ratio despite a decrease in full-year net income due to a planned turnaround.
Worse than expected
NYSE
Westlake Chemical Partners LP announces the retirement of M. Steven Bender as Executive Vice President and Chief Financial Officer, effective upon successor appointment.
NYSE
Westlake Chemical Partners LP announced the renewal of its critical Ethylene Sales Agreement with Westlake Corporation through 2027, maintaining stable terms, alongside reporting Q3 2025 financial results.
Worse than expected
Quarterly Earnings (10-Q)
See all →NYSE
Westlake Chemical Partners LP reported stable second-quarter revenues of $297.1 million, with net income attributable to the partnership increasing to $14.2 million, driven by improved operational efficiency and sales volumes.
Capital raise
NYSE
Westlake Chemical Partners LP reported a significant increase in net income and revenue for the first quarter of 2026, driven by higher ethylene production and sales.
Better than expected
NYSE
Westlake Chemical Partners LP reported a significant decline in third-quarter net income and distributable cash flow, primarily driven by increased feedstock and natural gas costs and lower third-party sales volumes, despite higher sales to Westlake.
Delay expected
Worse than expected
Capital raise
NYSE
Westlake Chemical Partners LP reported a decline in net income and distributable cash flow for the first half of 2025, primarily due to an extended Petro 1 facility turnaround and higher feedstock costs.
Delay expected
Worse than expected
Capital raise
NYSE
Westlake Chemical Partners LP's Q1 2025 net income decreased due to lower sales volumes from a planned maintenance turnaround and increased feedstock costs.
Delay expected
Worse than expected
NYSE
Westlake Chemical Partners LP saw a rise in net income for the third quarter of 2024, driven by higher third-party sales and lower feedstock costs, despite a decrease in overall net sales.
Better than expected
Delay expected
Annual Reports (10-K)
NYSE
Westlake Chemical Partners LP reported a decrease in net income and cash flow for 2025, primarily driven by higher feedstock costs and extended turnaround activities, despite a slight increase in net sales.
Worse than expected
Delay expected
Capital raise
NYSE
Westlake Chemical Partners LP announces its financial results for the fiscal year ended December 31, 2024, showcasing increased net income despite a slight decrease in net sales.
Better than expected
Capital raise
Delay expected
NYSE
Westlake Chemical Partners LP reports a decrease in net income attributable to the partnership for fiscal year 2023, despite an increase in income from operations.
Worse than expected
Capital raise
Insider Trading (Form 4)
See all →NYSE
Randy Woelfel, a Director of Westlake Chemical Partners LP, received 5,044 shares of common stock on August 12, 2026.
NYSE
G Stephen Finley, a Director of Westlake Chemical Partners LP, received 5,044 shares of common stock on August 12, 2026.
NYSE
Lisa A. Friel, a Director of Westlake Chemical Partners LP, received 5,044 shares of common stock on August 12, 2026.
NYSE
Lisa A. Friel, a Director of Westlake Chemical Partners LP, reported multiple transactions in common stock on August 6, 2026.
NYSE
Randy Woelfel, a Director of Westlake Chemical Partners LP, reported multiple transactions in common stock on August 6, 2026.
NYSE
G Stephen Finley, a Director of Westlake Chemical Partners LP, reported multiple transactions in common stock on August 6, 2026.
Proxy Statements (Def-14A)
NYSE
Westlake Chemical Partners LP has filed a definitive proxy statement with the SEC.
NYSE
Westlake Chemical Partners LP is holding a special meeting on May 8, 2024, to seek unitholder approval for extending its Long-Term Incentive Plan and ratifying the appointment of PricewaterhouseCoopers LLP as its independent auditor.
Schedule 13G - Passive Investments
NYSE
Energy Income Partners, LLC and its officers have reported a 4.44% beneficial ownership stake in Westlake Chemical Partners LP as of December 31, 2025.
NYSE
Energy Income Partners, LLC and its officers have disclosed a 5.04% beneficial ownership stake in Westlake Chemical Partners LP.
NYSE
Energy Income Partners, LLC and its principals have filed an amended Schedule 13G, disclosing a reduced beneficial ownership stake of 4.966% in Westlake Chemical Partners LP as of March 31, 2025.
Worse than expected